Home › Core › ISCC-IDs › 28C8L97ZDLoQX

View ISCC-ID

Core Data

28C8L97ZDLoQX
ISCC-ID - digital asset identifier
CCNSxeQUqiH2H-CTap1hWcF82qe-CDEtExWEGB3Mn-CRGX6nAwre2rb
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for adv

Ledger Reference

coblo
Source Ledger/Blockchain
12409599
N-th ISCC Decleration on source ledger
468f360b8b4dad458514ea68bae4f041ddb3acbad672aaaa580255a8ad320cc7
Hash of block that includes the ISCC-DECLARATION
340291abb10e750e1cbc637b3f0d36c40cbc949b5275bd5b4fcad494921b2446
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Kaoru Tsuchiya", "@type": "Person"}, {"name": "Yasuhiro Asahina", "@type": "Person"}, {"name": "Shuya Matsuda", "@type": "Person"}, {"name": "Masaru Muraoka", "@type": "Person"}, {"name": "Toru Nakata", "@type": "Person"}, {"name": "Yuichiro Suzuki", "@type": "Person"}, {"name": "Nobuharu Tamaki", "@type": "Person"}, {"name": "Yutaka Yasui", "@type": "Person"}, {"name": "Shoko Suzuki", "@type": "Person"}, {"name": "Takanori Hosokawa", "@type": "Person"}, {"name": "Takashi Nishimura", "@type": "Person"}, {"name": "Ken Ueda", "@type": "Person"}, {"name": "Teiji Kuzuya", "@type": "Person"}, {"name": "Hiroyuki Nakanishi", "@type": "Person"}, {"name": "Jun Itakura", "@type": "Person"}, {"name": "Yuka Takahashi", "@type": "Person"}, {"name": "Masayuki Kurosaki", "@type": "Person"}, {"name": "Nobuyuki Enomoto", "@type": "Person"}, {"name": "Namiki Izumi", "@type": "Person"}], "license": "cc-by-nc-nd", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc4209122?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Wiley", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1002/cncr.28384", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCNSxeQUqiH2H-CTap1hWcF82qe-CDEtExWEGB3Mn-CRGX6nAwre2rb", "propertyID": "ISCC"}], "datePublished": "2013-10-07"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close